ACTRN12606000238572招募中1 期
Feasibility and safety of erythropoietin (EPO) administration in patients with acute myocardial infarction (AMI) to improve cardiac function and remodelling.
Eastern Heart Clinic0 个研究点目标入组 20 人开始时间: 2006年6月14日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 ot stated（—）
- 性别
- All
入选标准
- •Acute ST elevation myocardial infarction that are treated with primary angioplasty and stenting who have significant left ventricular (LV) impairment.
排除标准
- •Multiple - but particularly major comorbidities.
研究者
相似试验
尚未招募
Unknown
To assess the effect of erythropoietin (EPO)in augmentation of peri implant tissues.CTRI/2023/08/056074one
终止
2 期
Erythropoietin Spinal Cord Compression Randomized TrialNerve Compression SyndromesNCT00220675Sunnybrook Health Sciences Centre7
已完成
4 期
Impact of Recombinant Human Erythropoietin (ior EPO-CIM) in oncology pediatric patients with post chemo and /or radiotherapy.Anemia secondary to chemo and/or radiotherapy.RPCEC00000080Center of Molecular Immunology(CIM)161
终止
3 期
Renal Graft Function After Treatment With Erythropoietin (EPO)IschemiaNCT01450878University Hospital, Limoges6
Unknown
4 期
Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell TransplantationHematopoietic Stem Cell TransplantationLymphomaAnemiaNCT03010579Peking University70